nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of phlebosclerotic colitis
|
Pan, Xia |
|
2015 |
39 |
6 |
p. 651-652 2 p. |
artikel |
2 |
A letter on ABCB4 from Iceland: On the highway to liver disease
|
Lammert, F. |
|
2015 |
39 |
6 |
p. 655-658 4 p. |
artikel |
3 |
Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases
|
Petit, Marie-Anne |
|
2015 |
39 |
6 |
p. 699-704 6 p. |
artikel |
4 |
Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature
|
Qi, Xingshun |
|
2015 |
39 |
6 |
p. 683-691 9 p. |
artikel |
5 |
CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis
|
Fu, Yong |
|
2015 |
39 |
6 |
p. 736-739 4 p. |
artikel |
6 |
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial
|
Pernot, Simon |
|
2015 |
39 |
6 |
p. e73-e77 nvt p. |
artikel |
7 |
Editorial board
|
|
|
2015 |
39 |
6 |
p. i- 1 p. |
artikel |
8 |
Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
|
Lu, Yi |
|
2015 |
39 |
6 |
p. 718-724 7 p. |
artikel |
9 |
For a better morpho-dynamic evaluation of the portal system in cirrhosis
|
Manenti, Antonio |
|
2015 |
39 |
6 |
p. e87-e88 nvt p. |
artikel |
10 |
Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: Active protagonist or innocent bystander?
|
Simondi, Daniele |
|
2015 |
39 |
6 |
p. 740-745 6 p. |
artikel |
11 |
Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis
|
Cengiz, Mustafa |
|
2015 |
39 |
6 |
p. 692-698 7 p. |
artikel |
12 |
Magnetic resonance cholangiography: Current and future perspectives
|
Arrivé, Lionel |
|
2015 |
39 |
6 |
p. 659-664 6 p. |
artikel |
13 |
Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy
|
Luo, Ming |
|
2015 |
39 |
6 |
p. 665-673 9 p. |
artikel |
14 |
Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis
|
Zhao, Li-Na |
|
2015 |
39 |
6 |
p. 674-682 9 p. |
artikel |
15 |
Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1
|
Akkız, Hikmet |
|
2015 |
39 |
6 |
p. 711-717 7 p. |
artikel |
16 |
Role of HCV-RNA decay and IP-10 levels after 48hours of standard HCV therapy as predictors of rapid virological response
|
Prinapori, Roberta |
|
2015 |
39 |
6 |
p. 705-710 6 p. |
artikel |
17 |
Sorafenib-induced hand-foot syndrome
|
Sioulas, Athanasios D. |
|
2015 |
39 |
6 |
p. 653-654 2 p. |
artikel |
18 |
Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands
|
van der Geest, Lydia G.M. |
|
2015 |
39 |
6 |
p. 725-735 11 p. |
artikel |
19 |
Tocilizumab for intestinal amyloidosis complicated by multi-centric Castleman's disease
|
Tamura, Tadahiko |
|
2015 |
39 |
6 |
p. e79-e81 nvt p. |
artikel |
20 |
Treatment of severe refractory de novo auto-immune hepatitis after liver transplantation with plasmapheresis
|
Dumortier, Jérôme |
|
2015 |
39 |
6 |
p. e83-e85 nvt p. |
artikel |